Cardioprotective and Vasodilatory Actions of Glucagon-Like Peptide 1 Receptor Are Mediated Through Both Glucagon-Like Peptide 1 Receptor–Dependent and –Independent Pathways-Reference-Cited by-同舟云学术

Cardioprotective and Vasodilatory Actions of Glucagon-Like Peptide 1 Receptor Are Mediated Through Both Glucagon-Like Peptide 1 Receptor–Dependent and –Independent Pathways

Published:2008-05-06 Issue:18 Volume:117 Page:2340-2350
ISSN:0009-7322
Container-title:Circulation
language:en
Short-container-title:Circulation

Author:

Ban Kiwon¹,Noyan-Ashraf M. Hossein¹,Hoefer Judith¹,Bolz Steffen-Sebastian¹,Drucker Daniel J.¹,Husain Mansoor¹

Affiliation:

1. From the Heart and Stroke Richard Lewar Centre of Excellence for Cardiovascular Research (K.B., M.H.N.-A., J.H., S.-S.B., M.H.), Department of Medicine (D.J.D., M.H.), Institute of Medical Science (J.H., D.J.D., M.H.), Department of Physiology (K.B., S.-S.B.), and Banting and Best Diabetes Centre (D.J.D.), University of Toronto; Samuel Lunenfeld Research Institute, Mount Sinai Hospital (D.J.D.); and Toronto General Hospital Research Institute, Toronto General Hospital (K.B., M.H.N.-A., J.H., M.H.),...

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Reference46 articles.

1. The biology of incretin hormones

2. Molecular evolution of proglucagon

3. Glucagon and Glucagon-Like Peptide Receptors as Drug Targets

4. Both amidated and nonamidated forms of glucagon-like peptide I are synthesized in the rat intestine and the pancreas.

5. Tissue-specific expression of the human receptor for glucagon-like peptide-I: brain, heart and pancreatic forms have the same deduced amino acid sequences

Cited by 888 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of sodium‐glucose cotransporter 2 inhibitors with risk of incident dementia and all‐cause mortality in older patients with type 2 diabetes: A retrospective cohort study using the TriNetX US collaborative networks;Diabetes, Obesity and Metabolism;2024-09-09

2. The role of glucagon-like peptide-1 receptor agonists (GLP1-RAs) in the management of the hypertensive patient with metabolic syndrome: a position paper from the Korean society of hypertension;Clinical Hypertension;2024-09-01

3. Novel Metabolites Associated With Blood Pressure After Dietary Interventions;Hypertension;2024-09

4. Glucagon-like peptide 1 agonist and effects on reward behaviour: A systematic review;Physiology & Behavior;2024-09

5. Molecular basis of enhanced GLP-1 signaling mediated by GLP-1(9-36) in conjunction with LSN3318839;Acta Pharmaceutica Sinica B;2024-09